A personalised medicine resource
Knowledge of the genetic mutations associated with different cancer types is increasing rapidly and is already influencing treatment choices.
The My Cancer Genome website is a database of information on genes, genetic mutations and cancer. It includes information on the latest research and the latest treatments across many cancer types (including bowel cancer).
The website also highlights the benefits of genetic testing especially when knowledge of a particular gene mutation can affect treatment decisions.
For example, RAS testing in bowel cancer patients can help decide whether they are likely to respond to specific targeted therapies such as Erbitux (cetuximab) or Vectibix (panitumumab).
Mutations in other genes such as BRAF, PIK3CA, AKT1, SMAD4, PTEN, NRAS, and TGFBR2F are also relevant for bowel cancer patients and their families.
For further details please visit the My Cancer Genome website.